Skip to content

Margin Status After Pancreaticoduodenectomy for Cancer

Margin Status After Pancreaticoduodenectomy for Cancer. Results of a Multicentric Prospective Randomized Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03267966
Enrollment
168
Registered
2017-08-31
Start date
2013-03-31
Completion date
2019-06-30
Last updated
2020-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ampullary Cancer, Cholangiocarcinoma, Pancreatic Cancer

Keywords

periampullary cancer, margin status, R1 resection, clearance margin

Brief summary

This multicentric prospective randomized controlled trial (RCT) compares the Leeds Pathology Protocol (LEEPP) with other conventional pathological protocol of PD specimen for periampullary cancer. Our aims were to evaluate the impact of the protocol and of the clearance on R1 rate and its prognostic value.

Interventions

DIAGNOSTIC_TESTLeeds Pathology Protocol (LEEPP)

LEEPP includes: 1) multicolor inking; 2) axial slicing; 3) circumferential margin; 4) 1-mm clearance

Sponsors

Humanitas Hospital, Italy
CollaboratorOTHER
Azienda Ospedaliero, Universitaria Pisana
CollaboratorOTHER
Medical University of Silesia
CollaboratorOTHER
Campus Bio-Medico University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* pancreaticoduodenectomy for periampullary cancer

Exclusion criteria

* diagnosis of neuroendocrine neoplasm; * previous pancreatic surgery; * frozen section of each transection margins not performed or presence of positive transection margins without further resection (R1 intraoperative resection); * presence of macroscopic residual tumor (R2 resection).

Design outcomes

Primary

MeasureTime frameDescription
R1 resection rate1 monthTo evaluate difference in terms of R1 resection rates between study groups with 0-mm and 1-mm clearance

Secondary

MeasureTime frameDescription
pathological data1 monthTo evaluate differences in pathological results (T status, N status, number of blocks, number of lymphnodes, etc) between the two study groups
oncological results60 monthsTo evaluate the correlation between R1 resection and oncological results (local recurrence, overall survival) in the two study groups

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026